Replies to post #11113 on GTC Biotherapeutics (fka GTCB)

[goatfondler]

Look at the performance of GTCB after Atryn was approved in 2006 and you'll find a company that has sputtered. I think management has a lot to do with it and not circumstances, unless the company is being manipulated in some fashion that we do not know about.